UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000035548
Receipt number R000040309
Scientific Title Acquisition of intestinal environment data through the individual intestinal environment evaluation service
Date of disclosure of the study information 2019/01/16
Last modified on 2020/01/15 10:16:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Acquisition of intestinal environment data through the individual intestinal environment evaluation service

Acronym

Acquisition of intestinal environment data through the individual intestinal environment evaluation service

Scientific Title

Acquisition of intestinal environment data through the individual intestinal environment evaluation service

Scientific Title:Acronym

Acquisition of intestinal environment data through the individual intestinal environment evaluation service

Region

Japan


Condition

Condition

Men and Women

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Acquisition of intestinal environment data through the evaluation service provided by Metabologenomics, Inc.

Basic objectives2

Others

Basic objectives -Others

Research

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Intestinal environment evaluation based on microbiota analysis and metabolomics analysis

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) User of intestinal environment evaluation service or related services provided by Metabologenomics, Inc.
2) Subjects who show understanding of the study procedures and agreement with participating the study by written informed consent appeared on website of Metabolognomics, Inc. prior to the study. In case of minor and/or person who don't have ability to agree, the agreement by substitute person is necessary.
3) If the subjects are minor and/or person who don't have ability to conduct the collection of sample and answering questionnaire by themselves, appropriate person to support or substitute their operation is necessary.

Key exclusion criteria

1) Subjects who may have difficulty to collect the stool along the procedure instructed by Metabologenomics, Inc.
2) Subjects with suspected infection.
3) Subjects who have been determined as ineligible for participating the research by principal investigator.

Target sample size

100000


Research contact person

Name of lead principal investigator

1st name Shinji
Middle name
Last name Fukuda

Organization

Metabologenomics, Inc.

Division name

Headquarters

Zip code

997-0051

Address

246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata, Japan

TEL

+81-235-64-0330

Email

research@metagen.co.jp


Public contact

Name of contact person

1st name Shinosuke
Middle name
Last name Murakami

Organization

Metabologenomics, Inc.

Division name

Headquarters

Zip code

997-0051

Address

246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata, Japan

TEL

+81-235-64-0330

Homepage URL


Email

mgnavi@metagen.co.jp


Sponsor or person

Institute

Metabologenomics, Inc.

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiyoda Paramedical Care Clinic

Address

3-3-5 Uchikanda, Chiyoda-ku, Tokyo

Tel

03-5297-5548

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 10 Month 04 Day

Date of IRB

2018 Year 10 Month 04 Day

Anticipated trial start date

2019 Year 01 Month 16 Day

Last follow-up date

2035 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This research is aimed at acquiring the various intestinal environments data from people who use the intestinal environment evaluation service or related services provided by Metabologenomics, Inc.


Management information

Registered date

2019 Year 01 Month 15 Day

Last modified on

2020 Year 01 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000040309


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name